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Slow wave activity topographySleep slowwave activity (SWA), themajor electrophysiological characteristic of deep sleep, mirrors both cortical
restructuring and functioning. The incidence of Major Depressive Disorder (MDD) substantially rises during the
vulnerable developmental phase of adolescence,where essential cortical restructuring is taking place. The goal of
this studywas to assess characteristics of SWA topography in adolescentswithMDD, in order to assess abnormal-
ities in both cortical restructuring and functioning on a local level. All night high-density EEGwas recorded in 15
patientsmeeting DSM-5 criteria forMDDand 15 sex- and age-matched healthy controls. The actual symptom se-
verity was assessed using the Children's Depression Rating Scale—Revised (CDRS-R). Topographical powermaps
were calculated based on the average SWA of the ﬁrst non-rapid eye movement (NREM) sleep episode. De-
pressed adolescents exhibited signiﬁcantly more SWA in a cluster of frontal electrodes compared to controls.
SWA over frontal brain regions correlated positively with the CDRS-R subscore “morbid thoughts”. Self-
reported sleep latency was signiﬁcantly higher in depressed adolescents compared to controls whereas sleep ar-
chitecture did not differ between the groups. Higher frontal SWA in depressed adolescents may represent a
promising biomarker tracing cortical regions of intense use and/or restructuring.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Depression is one of the leading causes of disease burdenworldwide
(Hyman et al., 2006). It is a highly disabling, often chronic illness, asso-
ciated with increased risk of suicide (Ferrari et al., 2013). The incidence
of Major Depressive Disorder (MDD) is relatively low in younger
children (Kessler et al., 2001), yet rises substantially throughout adoles-
cence (Green et al., 2005), with an almost twofold increase of the life-
time prevalence between age 13 (8.4%) and 18 (15.4%) (Merikangas
et al., 2010). This increasing emergence of depression during a vulnera-
ble developmental period (Blakemore and Choudhury, 2006) coincides
with pronounced structural and functional modiﬁcations in the brain
(Paus et al., 2008). These alterations are not paused during sleep, in con-
trast, sleep is considered an active process, also in the development of
the central nervous system (Hobson and Pace-Schott, 2002). Increasing
evidence suggests a close relationship between sleep and cortical
plasticity (Diekelmann and Born, 2010; Tononi and Cirelli, 2014).ital Zurich, Steinwiesstrasse 75,
. This is an open access article underSpeciﬁcally, the slow ﬂuctuations of cortical activity during deep sleep,
visible in the surface electroencephalography (EEG) as slow waves
(Steriade et al., 1993) and measured as slow wave activity (SWA; fre-
quency range 0.75–4.5 Hz), have been shown to mirror the extensive
synaptic reorganization of cortical areas from early childhood to late ad-
olescence (Campbell and Feinberg, 2009; Kurth et al., 2010). SWA is fur-
ther closely related to efﬁcient cognitive functioning (Born et al., 2006;
Tononi and Cirelli, 2014) and may be involved in the consolidation of
memories related to emotions, thoughts and actions (Rasch and Born,
2013). Reported sleep disturbances as a core symptom of MDD and al-
tered sleep structure have long been amajor area of research in depres-
sion. In depressed adults, alterations in sleep structure such as
decreased slow wave sleep are quite consistently observed (Benca
et al., 1992; Borbely and Wirz-Justice, 1982) and have been proposed
as biomarkers predicting treatment response to a speciﬁc antidepres-
sant or even the course of the disorder (Steiger andKimura, 2010). Find-
ings related to sleep structure in youth have been inconsistent so far
(Riemann et al., 2001; Tesler et al., 2013).
As a major marker of the homeostatic regulation of sleep, several
studies investigated sleep SWA in the context of MDD. Results of these
studies in adults are inconsistent showing reduced (Armitage et al.,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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after sleep deprivation (Frey et al., 2012). To our knowledge, only one
study up to now focused on SWA in depressed adolescents, reporting
lower SWA in depressed males compared to controls (Lopez et al.,
2012). However, none of the previous studies used high-density EEG
(hdEEG) to investigate topographical aspects of the SWA distribution.
Therefore, the main emphasis of our study was to investigate SWA
topography in adolescents diagnosed with MDD by means of hdEEG,
to detect abnormalities in both cortical restructuring and functioning
on a local level.
2. Methods
2.1. Participants
Fifteen children and adolescents (age range: 12.9–16.6 years,
mean± SEM: 15.1 ± 0.3) meeting criteria of a Major Depressive Disor-
der, single episode or recurrent, according to DSM-IV and DSM-5
(American Psychiatric Association, 1994, 2013) were recruited from
in- andoutpatient settings at theUniversity Clinics for Child andAdoles-
cent Psychiatry, University of Zurich, Switzerland.
DSM diagnoses were assessed by two child and adolescent psychia-
trists using the Mini International Neuropsychiatric Interview for Chil-
dren and Adolescents (MINI-KID), a semi-structured interview for
children and adolescents (Sheehan et al., 2010). Past psychiatric illness
and treatment information was obtained from the parent/guardian and
augmented by medical chart information. The actual symptom severity
was further assessed using the Children's Depression Rating Scale-
Revised (CDRS-R) (Poznanski and Mokros, 1996); (Keller et al., 2011).
The total sum score as well as ﬁve subscores (Guo et al., 2006)
(observed depressive mood; anhedonia; morbid thoughts; somatic
symptoms; reported depressive mood) were derived. Clinical and func-
tional impairment were assessed using the Clinical Global ImpressionTable 1
Sample characteristics.
Sample characteristics
Age, years, mean ± SEM, range
Sex, female, N (%)
IQ, mean ± SEM, range
Socio Economic State Scale, mean ± SEM, range
Tanner Pubertyscale, mean ± SEM, range
Current DSM-5 Diagnoses, N (%)
Major Depressive Disorder (MDD)
Anxiety Disorders
Panic Disorder
Social Phobia
Speciﬁc Phobia
Neurodevelopmental and conduct disordersd
ADHD
Conduct Disorder
Characteristics of illness and functioning, mean ± SEM, range
Total duration of illness, weeks
Duration of current MDD episode, weeks
Actual Severity of Depression, CDRS-R Sum Score
Illness Severity: Clinical Global Impressions-Severity Scale
Current Functional Level: Global Assessment of Functioning-Scale
Treatment setting and medication at time of the sleep recordings
Inpatients/Day-Clinics/Outpatients (%)
Receiving psychotropic medication, N (%)e
Medication class, N (%)
Selective-Serotonin-Reuptake-Inhibitorsf
Noradrenergic and Speciﬁc Serotonergic Antidepressant (Mirtazapine)
Atypical Antipsychotic (Quetiapine)
N/A = not available;
a Data available for 8 adolescents.
b Data available for 2 adolescents.
c Data available for 9 adolescents.
d The total number of patients in one diagnostic category can be smaller than the sum of th
e The total number of patients receiving psychotropic medication is smaller than the sum of
f Selective-Serotonin-Reuptake-Inhibitors include Fluoxetin (N= 4), Citalopram (N=1), SeScale (CGI) (Guy, 1976) and the Global Assessment of Functioning
(GAF) (Hall, 1995). Self reported pubertal status and parental socio-
economic status of all participants were assessed using the Tanner
scales (Carskadon and Acebo, 1993) and the Hollingshead socio
economic state scale (Hollingshead, 1975), respectively. The Wechsler
Intelligence Scale for Children WISC IV (Daseking et al., 2007) and for
2 control participants the TONI-IV (Brown et al., 1997), were used to as-
sess overall cognitive performance.
Exclusionary psychiatric disorders were: schizophrenia, bipolar dis-
order, autism spectrum disorder, eating disorder, and substance-
dependence. Other comorbidities frequently present in adolescents
withMDD such as anxiety or attention-deﬁcit disorders were permitted
(Kessler et al., 2003), given that MDD was the primary diagnosis (see
Table 1 for details). Participants with an intelligence quotient
(IQ) b 85 (Brown et al., 1997; Daseking et al., 2007) and a medical/neu-
rological condition known to affect the brain were also excluded.
At the time of the sleep recordings, adolescent patients with depres-
sion had an actual severity of depressive symptoms between 21 and 61
(mean score 41.7 ± 3.0). The mean (±SEM) duration of the current
MDD episode was 39.5 (±7.8) weeks and the total illness duration
was 95.3 (±18.6) weeks (Table 1). The depressed patients weremostly
treated in an inpatient setting (n = 8, 53%), followed by day-clinics
(n = 4, 27%) and outpatient settings (n = 3, 20%). The majority of the
patients received selective-serotonin-reuptake-inhibitors (SSRIs)
(n = 9, 60%) (Table 1). One patient additionally received a tricyclic an-
tidepressant (Mirtazapine), one patient was treated with atypical anti-
psychotic medication (Quetiapine) and ﬁve patients (n = 5, 33%)
were medication naive (Table 1).
Fifteen healthy controls were sex- and age-matched to the patient
group (age range: 12.8–16.4 years, mean ± SEM: 15.3 ± 0.3). They
underwent a telephone and questionnaire screening to exclude person-
al and family history of psychiatric disorders, chronic diseases, learning
disabilities, sleep disorders and use of psychotropic medication.Depressed (N = 15) Controls (N = 15)
15.1 ± 0.3, 12.9 - 16.6 15.3 ± 0.3, 12.8 - 16.4
8 (53) 8 (53)
113.5 ± 2.6, 98.0 - 129.0 115.8 ± 6.1a, 102.0 - 131.0
5.3 ± 0.4, 2.0 - 8.0 3.5 ± 0.4b, 3.0 - 4.0
9.7 ± 0.3, 7.0 - 11.0 9.5 ± 0.8c, 7.0 - 12.0
15 (100) N/A
6 (40)
1 (7) N/A
4 (27) N/A
2 (13) N/A
4 (27)
4 (27) N/A
2 (13) N/A
95.3 ± 18.6, 13.0 - 295.0 N/A
39.5 ± 7.8, 13.0 - 108.0 N/A
41.7 ± 3.0, 21.0 - 61.0 N/A
4.5 ± 0.2, 3.0 - 6.0 N/A
52.8 ± 4.0, 21.0 - 90.0 N/A
8/4/3 (53/27/20) none
10 (67) none
9 (60) none
1 (7) none
1 (7) none
e individual diagnoses due to comorbidity.
the agents due to one patient who received Sertraline and Mirtazapine.
rtraline (N= 4). Differenceswere compared by using two tailed, unpaired Student’s t-test.
Table 2
Reported and visually scored sleep variables.
Depressed mean ±
SEM, range
Controls mean ±
SEM, range
Reported sleep times
Reported sleep latency (min) 31.2 ± 6.9*, 10.0–120.0 19.0 ± 2.3, 5.0 - 30.0
Total time in bed (weekdays) 8.9 ± 0.4, 6.7 - 11 9.6 ± 0.2, 8.8 - 10.9
Total time in bed (weekends) 10.3 ± 0.4, 7.3 - 12.2 10.4 ± 0.2, 9.0 - 11.8
Total sleep time (weekdays) 7.3 ± 0.2, 5.8 - 8.5 7.9 ± 0.2, 6.9 - 8.9
Total sleep time (weekends) 8.9 ± 0.4, 6.8 - 10.8 9.5 ± 0.2, 8.8 - 10.3
Visually scored sleep variables
Sleep latency (min) 18.5 ± 3.6, 4.7 - 50.3 22.3 ± 4.1, 6.3 - 55.3
REMS latency (min) 109.1 ± 8.3, 62.3 - 172.0 140.4 ± 13.4, 78.3 - 220.3
Wake after sleep onset (min) 13.2 ± 3.4, 2.7 - 55.0 21.2 ± 4.4, 4.7 - 66.7
Sleep stage 1 (%) 6.3 ± 1.0, 2.8 - 14.1 6.7 ± 0.6, 3.6 - 10.6
Sleep stage 2 (%) 50.3 ± 1.7, 36.8 - 59.3 52.8 ± 1.1, 43.9 - 58.3
Sleep stage 3 (%) 22.7 ± 2.0, 14.2 - 44.0 22.7 ± 1.3, 14.4 - 32.3
REMS (%) 20.7 ± 1.8, 12.2 - 28.7 17.7 ± 1.3, 10.7 - 26.9
Total sleep time (min) 429.6 ± 23.8, 344.0 - 529.3 427.9± 17.6, 272.7 - 540.3
Total time in bed (min) 462.4 ± 21.4, 407.0 - 552.0 468.8± 14.5, 365.3 - 565.0
Sleep efﬁciency (%) 92.0 ± 2.0, 84.5 - 98.8 90.9 ± 1.5, 74.6 - 97.7
Reported sleep times: Reported sleep latency in minutes, total time in bed on weekdays in
hours, total time in bed onweekends in hours, total sleep time onweekdays in hours, total
sleep time on weekends in hours; Visually scored sleep variables: Sleep latency inminutes,
rapid eye movement (REM) sleep latency in minutes, wake after sleep onset in minutes,
sleep stage 1 in percent (%), sleep stage 2 in %, sleep stage 3 in %, REM sleep in %, total
sleep time in minutes, total time in bed in minutes and sleep efﬁciency in %. Differences
were compared by using two tailed, unpaired Student’s t-test. * Represent signiﬁcant dif-
ferences (p ≤ 0.05).
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minors, and an additional written assent was obtained from each
minor after careful explanation of the studymethods and aims. The pro-
cedureswere approved by the local ethics committee and the studywas
performed according to the Declaration of Helsinki. All subjects were
non-smokers. One week prior to the study, all participants were
instructed to maintain regular sleep–wake schedules according to
their habitual bedtimes and to keep their caffeine consumption on re-
stricted levels. Compliance was monitored with self-reported sleep
logs and wrist motor actigraphy (Actiwatch Plus, AW4, Cambridge
Neurotechnology, Cambridge, England). Visual inspection of this data
showed in none of the subjects deviations from the instructions. To in-
vestigate the process of differential adaptation to the sleep laboratory
in the two groups, we analyzed the reported prior total time in bed
and total sleep time during both, weekdays and weekends. In addition,
all participants were asked to protocol their alcohol consumption, their
smoking habits as well as use of medication, by indicating time of the
day and amount of drug intake or state ‘no drug consumption at all’ in
a diary. According to these protocols, all participants were non-
smokers and did not drink alcohol one week prior to measurement
night. Twenty-four hours before the sleep assessment, they were
asked to refrain from alcohol, caffeine and to avoid naps. At study
entry, participants underwent a questionnaire screening where they
were asked to report on their habitual sleep parameters, including
total sleep time and sleep latency.
2.2. Recording and preprocessing of EEG data
All EEG data were collected in the sleep laboratory of the University
Children's Hospital Zurichwith a hd EEG device (Electrical Geodesic Inc.
Sensor Net for a long-term monitoring, 128 channels). The net sizes
were selected according to the head circumference of each participant.
Next, the nets were adjusted to the vertex and the cap electrodes
were ﬁlled with gel electrolyte. The nets were adjusted to each partici-
pants' head to ensure stability of the nets in the course of the night. Im-
pedances weremeasured at the beginning and end of the recording and
were stable below 50 kΩ. The sleep episode of each participant was
scheduled according to habitual bedtimes.
EEG recordings were sampled at 500 Hz (ﬁltered between 0.01–
200 Hz) and referenced to the vertex (Cz). The data was then band-
pass ﬁltered between 0.5 and 50 Hz and downsampled to 128 Hz.
After visually scoring for sleep stages (20 s epochs, American Academy
of Sleep Medicine standard criteria (Iber et al., 2007)), artefacts were
rejected on a 20 s basis after visual inspection and if power exceeded
a threshold based on a mean power value in the 0.75–4.5 and 20–
30 Hz bands (Kurth et al., 2010). After exclusion of EEG channels of in-
sufﬁcient quality (on average, 2 channels per participant) the data
was rereferenced to average reference. Sleep cycles including NREM
and REM sleep episodes were deﬁned according to the criteria of
(Feinberg and Floyd, 1979).
2.3. EEG power analysis, spectral analysis and statistics
Weperformed spectral analysis of consecutive 20 s epochs (fast Fou-
rier transform routine, Hanningwindow, averages ofﬁve 4 s epochs, fre-
quency resolution of 0.25 Hz). To assess topographical differences
between the groups, SWA was calculated as mean power in the range
of 1–4.5 Hz during the ﬁrst NREM sleep episode. We selected this time
interval to account for differences in sleep episode durations and be-
cause it belongs to the most consolidated part of sleep. To assess signif-
icant topographical differences in SWA between the groups and to
deﬁne a speciﬁc region of interest, we applied statistical nonparametric
mapping (SnPM) using a suprathreshold cluster analysis for multiple
comparisons (Nichols and Holmes, 2002) as done in previous studies
(Huber et al., 2004; Kurth et al., 2010; Ringli et al., 2013). To evaluate
a possible effect of medication, we performed an exploratory analysis,by splitting the patient group into a group with (N=10) and a group
without medication (N=5) (for more details see Supplemental Figures
2 and 3). Anatomical localization of electrodes was veriﬁed in previous
studies (Kurth et al., 2012) using magnetic resonance imaging (MRI)
and the positioning software SofTaxic Optic (EMS Inc). Electrodes
were digitized and co-registered with the subject's MRI (for details see
(Kurth et al., 2012)). We found a high agreement between the align-
ment of the electrode location and the corresponding anatomical area
in a previous study (Kurth et al., 2012). To correct for multiple compar-
isons across the 0-20Hz frequency band (0.25 Hz steps), we used a false
discovery rate (FDR) correction. Two-way analysis of variance (ANOVA)
was performed with group and sex as independent factors and SWA as
dependent factor. Pearson product–moment correlation coefﬁcients
were calculated to assess relationships between SWA and actual symp-
tom severity (CDRS-R total score and subscores) in the affected sample.
Because the datawas normally distributed all other variableswere com-
pared between the groups by using unpaired t-tests. Data variability is
described as standard error of the mean (SEM) and range. All analyses
were performed with the software package MATLAB (MathWorks)
and SPSS 20.0.3. Results
3.1. Sleep architecture
First, to evaluate any potential differences in sleep duration before
entering the study, we compared the reported habitual total time in
bed and total sleep time for both groups. There were no signiﬁcant
group differences (p= 0.1 – 0.7, range of p-values for the four compar-
isons) (Table 2). Next, we examined visually scored sleep variables of
the experimental night to evaluate the sleep quality of the samples.
Sleep quality was comparably good in both groups, thus showing high
sleep efﬁciency (N90%). All other sleep stage measures were compara-
ble between the groups with no signiﬁcant differences (Table 2). Only
the self-reported sleep latencywas signiﬁcantly higher in depressed ad-
olescents compared to controls (31.2±6.9 vs. 19.0±2.3min, p=0.05)
(Table 2).
Fig. 1. (a, b). Topographical distribution of SWA (EEG power between 1–4.5 Hz) for the ﬁrst NREM sleep episode in depressed subjects (a) and healthy, age- and sex-matched control sub-
jects (b). Values are colour coded (maxima in red, minima in blue) and plotted on the planar projection of the hemispheric scalp model. The numbers in the right upper corner of each
topographical plot represent the maximal (red) and minimal (blue) value of SWA. (c, d). Topographical distribution of the difference in SWA between depressed and control subjects
(ratio depressed/controls). Values are colour coded (group differences in percentage %). SWA was increased by 43.7% (±1.7% SEM) at a frontal cluster of 9 electrodes (c), indicated as
grey dots (p b 0.05, SnPM, suprathreshold cluster test controlling for multiple comparisons, Nichols and Holmes, 2002) (d).
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to healthy controls
To investigate the topography of sleep SWA in adolescents with
depression, we calculated EEG power maps for each group. TheFig. 2. Slowwave activity time course in the cluster of 9 electrodes showing a signiﬁcant differe
Fig. 1) for the ﬁrst 4 NREM sleep episodes. When we normalized SWA, by dividing SWA for ea
SWA, SWA in the frontal cluster remained signiﬁcantly higher from the ﬁrst to the third NREM
ﬁrst NREM sleep episode (p b 0.01, two tailed, unpaired Student's t-test) (b). There were no sig
shown).topographical distribution of absolute values of SWA in the ﬁrst NREM
sleep episode showed regional differences with maxima over the frontal
cortex and minima over the temporal lobes (Fig. 1a and b). When con-
trasting the maps, we found higher SWA over the frontal cortex in de-
pressed adolescents (Fig. 1c and d). Compared to age- and sex-matchednce between depressed (n= 15) and healthy, age- and sex-matched control subjects (see
ch electrode by the average SWA across all electrodes, to account for differences in global
sleep episode (p b 0.05, two tailed, unpaired Student's t-test) (a). SWAwas different in the
niﬁcant group differences in the timing and length of the NREM sleep episodes (data not
Fig. 3. EEG power spectra for the cluster of 9 electrodes showing signiﬁcant differences in
SWA between depressed and control subjects during the ﬁrst NREM sleep episode. * indi-
cate frequency bins forwhich power in the depressed group (n=15) differed signiﬁcant-
ly (p b 0.05) from the controls (two tailed, unpaired Student's t-test).
254 N. Tesler et al. / NeuroImage: Clinical 10 (2016) 250–256controls, depressed adolescents exhibited 43.7% (±1.7%, p = 0.01) more
SWA in a cluster of 9 frontal electrodes (SnPM, see Methods for details;
Fig. 1d).
To evaluate the effects of sex, a two-way ANOVA conﬁrmed a signif-
icant group effect with higher frontal SWA in the cluster of 9 frontal
electrodes for the ﬁrst NREM sleep episode in depressed adolescents
(F(1,26) = 9.7, p = 0.004) but showed no effect of sex (F(1,26) = 0.8,
p = 0.4) and no interaction sex x group (F(1,26) = 1.6, p = 0.2).
For an anatomical localization of the frontal cluster, orthogonal pro-
jection of the electrodes onto the cortex localized all 9 electrodes to the
frontal lobe, superior frontal gyrus (8 electrodes to Brodmann area (BA)
10 and 1 electrode to BA 8).
3.3. SWA time course across the sleep cycles
As expected, SWA was increased during the ﬁrst NREM sleep epi-
sode, but we found no statistically signiﬁcant differences during the fol-
lowing episodes (Fig. 2). When we normalized SWA for each electrode
by the average across all electrodes, to account for differences in global
SWA, SWA in the frontal cluster remained signiﬁcantly higher from the
ﬁrst to the third NREM sleep episode in depressed adolescents com-
pared to age- and sex-matched controls (Fig. 2).
3.4. Frequency-speciﬁc frontal increase in depressed adolescents
In order to assesswhether the observed frontal increase in SWAwas
restricted to the SWA frequency range (b4.5 Hz), we examined the en-
tire frequency spectrum.We found that the increase in SWA in the 9 sig-
niﬁcant frontal electrodes was speciﬁc for the low frequency range
(b2 Hz) in the depressed group (Fig. 3) compared to controls (p =
0.02, FDR corrected).
3.5. Associations with actual symptom severity
We further investigated the relationship between SWA and actual
symptom severity in the affected group. Positive correlations between
SWA over frontal brain regions and the CDRS-R subscore for morbid
thoughts (r= 0.62, p= 0.01)were found. Three of 11 electrodes show-
ing a signiﬁcant correlation were located over BA 10.
4. Discussion
Our study found that the topographical distribution of sleep SWA in
adolescents diagnosed with Major Depressive Disorder (MDD) shows a
particular patternwith increased SWAover the frontal cortex compared
to healthy individuals. We further examined the topographicaldistribution of EEG power in the alpha, beta, sigma, and theta frequency
ranges and found no other frequency range showing such differences
(for more details see Supplemental Figure 1). Thus, the differences we
observe are speciﬁc for the low frequency range. Self-reported sleep his-
tory was not different between the groups. Concerning the night spent
in the laboratory, both groups slept equally well. Sleep efﬁciency
(group means from 91 to 92%) was concordant with laboratory-based
measures reported from other studies (Mason et al., 2008). Whereas
changes in sleep structure in depressed adults such as reduced slow
wave sleep and reduced REM latency were quite consistent (Reynolds
and Kupfer, 1987), studies in depressed children and adolescents re-
vealed inconsistent outcomes (Tesler et al., 2013). In line with our re-
sults, several studies reported no signiﬁcant group differences in any
sleep variable (Dahl et al., 2003; Emslie et al., 1990). In contrast, two
longitudinal studies reported altered sleep structure, such as reduced
REM sleep latency and more REM sleep, to precede and co-occur in ad-
olescents with depression (Dahl et al., 1996; Rao et al., 2002).
Regarding sleep SWA, previous ﬁndings showed that the topogra-
phy of SWA is characterized by local maxima with an age-dependent
shift from occipital areas during early childhood, central areas in late
childhood to frontal areas in late adolescence (Kurth et al., 2010). This
age shift in SWA seems to parallel the anatomical maturation which is
supported bymagnetic resonance imaging studies showing that cortical
development follows a similar posterior-anterior time course (Sowell
et al., 2004). In our adolescent patients with MDD such a typical age-
speciﬁc frontal predominance was detected, however, compared to
healthy controls, we identiﬁed signiﬁcantly higher SWA values over a
cluster of frontal electrodes. This cluster of 9 electrodes was localized
over the frontal lobe, superior frontal gyrus (BA 8 and 10). To our
knowledge, this is the ﬁrst study investigating the topographical distri-
bution of SWA in depressed adolescents with hdEEG. Using single elec-
trodes, a study found SWA to be lower inmale adolescents compared to
healthy controls, but reported no differences in female adolescents
(Lopez et al., 2012). However, from this study we do not knowwhether
the reduced SWA in male subjects was speciﬁc for a certain region or
was present globally. A global difference might indicate a relation-
ship to changes in sleep structure affecting SWA in a similar way at
all electrodes. In line with our results, a recent study (Frey et al.,
2012) showed higher SWA in depressed female young adults com-
pared to healthy controls. Even though we statistically ruled out an
effect of sex on our ﬁndings, larger as well as longitudinal studies
of pre- and postpubertal children and adolescents are needed to fur-
ther disentangle the complex interaction between maturation, sex
and onset of depression.
What might the local increase of SWA over frontal regions re-
ﬂect? Since SWA topographically peaks over areas of extensive syn-
aptic reorganization during healthy development (Kurth et al.,
2012; Wilhelm et al., 2014), the increase of frontal SWA in depressed
adolescents may reﬂect an altered pruning of synapses in this area,
such as a failure to reduce irrelevant and/or dysfunctional connec-
tions which may then result in more pronounced frontal cortical
thickness (Ducharme et al., 2014; Reynolds et al., 2014). Thus, the in-
creased frontal SWA in adolescent-onset depression may represent
an early deviant neurodevelopmental pattern. The observation that
SWA is positively associated with cortical thickness (Buchmann
et al., 2011) and a recent structural imaging study showing thicker
right and left middle frontal gyrus (BA 46, including portions of BA
9 and BA 10) in depressed adolescents compared to controls further
support this hypothesis (Reynolds et al., 2014). Interestingly, a
longitudinal study correlated anxious/depressed symptom scores
with thickness of the right ventromedial prefrontal cortex and
found a negative association at younger ages, a positive association
from 15 years on and a shift in polarity occurring at about age 12
(Ducharme et al., 2014).
Beside the close association to maturational and structural process-
es, SWA was also found to be use dependent and regulated on a local
255N. Tesler et al. / NeuroImage: Clinical 10 (2016) 250–256level. More speciﬁcally, SWA is locally increased as a result of more in-
tense use during precedingwakefulness (Huber et al., 2004). Therefore,
the local increase of SWA in our sample could also reﬂect an increased
use of the frontal cortex during the day, such as maladaptive repetitive
ruminative thinking as hypothesized by Frey et al. (2012). Interestingly,
functional MRI studies reveal higher activation in themedial and dorso-
lateral prefrontal cortex and in limbic structures during rumination
(Cooney et al., 2010). Our result of a positive correlation between mor-
bid and suicidal ideation and frontal SWA,may further support the asso-
ciation between ruminative thinking and locally increased SWA. For this
use dependency speaks that the local differencewasmore prominent at
the beginning of the sleep period. Typically, use dependent increases of
SWA are reduced in the course of the night reﬂecting the recovery func-
tion of sleep (Borbely and Achermann, 2005). However, normalized
SWA in the signiﬁcant cluster is persistently increased across the night
which rather supports a stable trait. Thus, the observed SWA changes
may reﬂect short-term use dependent processes which might interact
with long-term cortical reorganizational processes. In this regard, fre-
quently increased daytime use of speciﬁc brain regions, during a period
where major neurobiological modiﬁcations occur, could alter the time
course of typical healthy cortical restructuring.
Sleep slow oscillations are also considered an ideal basis for informa-
tion processing and transfer within a speciﬁc circuit (Diekelmann and
Born, 2010). Thus, an “over-activation” of slow oscillations may facili-
tate an engraving of dysfunctional negative biased thoughts and pave
the way for the onset of the disease. The observed difference between
objective and subjective sleep measures in our depressed adolescents
may be an indication for such negative biases and altered memories
(Taylor Tavares et al., 2008). This observation ﬁts well with Beck's cog-
nitive model of depression (Beck, 2008), which assigns biased acquisi-
tion and information processing a key role in the development and
maintenance of depression. A puzzling question is therefore, whether
sleep, i.e. sleep slow waves, are actively involved in the formation of
maladaptive neuronal responses. Support for a “depressogenic” role of
sleep slow waves comes from selective slow wave sleep deprivation in
depressed adults which result in an amelioration of depressive symp-
toms (Landsness et al., 2011). However, so far selective slow wave
sleep deprivation has not been investigated in adolescents with MDD.
If indeed negative biases are related to frontal SWA, we might expect
such a relationship also to be present in healthy participants. In an ex-
ploratory analysis of a sample of 31 healthy adolescents and young
adults (16.9± 0.7 years) selected from ongoing studies in our laborato-
ry, who had no personal and family history of psychiatric disorders,
learning disabilities, sleep disorders or use of medication, we correlated
the difference in objective and subjective sleep latency and frontal SWA.
Indeed, we found a signiﬁcant positive correlation between the differ-
ence in objective and subjective sleep latency and SWA in the ﬁrst
NREM sleep episode in the same cluster of 9 frontal electrodes (r =
0.5, p = 0.002; Pearson product–moment correlation; r = 0.4, p =
0.02, partial correlation, controlling for the effect of age). In another pre-
liminary analysis of 7 unaffected siblings of our depressed patients, we
found a trend for a higher self-reported sleep latency (p = 0.07) and
more importantly a similar increase in SWA in the ﬁrst NREM sleep ep-
isode over the cluster of 9 frontal electrodes compared to age- and sex
matched controls (group, F(1,12) = 7.2, p = 0.02). These results sup-
port the notion that negative biases and altered memories possibly
exist as part of a continuum, depend on the same neurobiological sys-
tem as sustained depressive symptoms and that SWA may be an early
marker to detect alterations within this system.
When discussing these results we should keep in mind some limit-
ing factors of our study. We did not include an adaptation night for
our young participants. In this regard, previous studies showed no
ﬁrst night effects in youth, i.e. reported no signiﬁcant differences in
sleep parameters when comparing the ﬁrst to the second night spent
in the laboratory (Browman and Cartwright, 1980; Coble et al., 1974).
In our study, both groups showed high sleep efﬁciency and nosigniﬁcant differences in sleep structure, especially no group differences
in sleep latency. In addition, self-reported total time in bed as well as
total sleep time during both, weekdays and weekends, did not signiﬁ-
cantly differ between our participants with MDD and our healthy con-
trols one week prior to assessment (Table 2). The setting was new and
similar for all study participants during the night spent in our sleep lab-
oratory. Thus, we assume no important impact of adjustment processes
in our samples of adolescents. Due to the naturalistic design of the
study, the use of medication is present in most of the depressed adoles-
cents, and it is unclear how these medications might have inﬂuenced
SWA. Particularly, 60% of our young patients received SSRIs, which
were shown to alter REM sleep and overall sleep efﬁciency, both of
which did not differ between our groups. In contrast, no effects of
SSRIs on slow wave sleep have been reported in adults (Nicholson and
Pascoe, 1988; Saletu et al., 1991; Tesler et al., 2013). Furthermore, a pre-
liminary report assessing 6 depressed children showed no effects of
SSRIs on deep sleep (Armitage et al., 1997). In our exploratory analysis,
we split the group of patients into a group with (N = 10) and a group
without medication (N = 5). Both groups show a frontal increase
SWA, the lack of statistical power limits a direct comparison (see Sup-
plemental Figures 2 and 3). Interestingly, the unaffected, unmedicated
siblings showed a similar frontal increase, thus a direct causative inﬂu-
ence of medication on SWA seems unlikely. The high rates of comorbid-
ities in the depressed group reﬂect a rather typical clinical sample
because anxiety disorders are the most frequent comorbid disorders
in children and adolescents with MDD. Next to social phobia, ADHD
was the most prevalent comorbidity in our sample. Interestingly, in a
sample of childrenwith the primary diagnosis of ADHD the SWA topog-
raphy showed a different pattern with lower SWA in frontal areas com-
pared to healthy controls, contrasting our ﬁnding of higher frontal SWA
in depressed adolescents (Ringli et al., 2013). However, considering
speciﬁc depressive cognitions such as morbid and suicidal thoughts,
we would assume similar neuronal circuits to be involved irrespective
of any comorbidity. Since our results point to an association of increased
SWA over frontal brain regions with morbid and suicidal thoughts, we
speculate that this association may be similar in all our depressed pa-
tient irrespective of comorbidities. Since depression during adolescence
may also precede other mental disorders such as bipolar disorder or
schizophrenia, follow-up investigations of the topographical distribu-
tion of SWA are necessary to tract deviant cortical development. Even
though all study participants underwent a screening to exclude person-
al and family history of psychiatric disorders and none of the controls
was in current or past psychiatric treatment, the screening questions
were not equivalent to the questions used in the MINI. Thus, we cannot
rule out that some individuals would have met criteria for a psychiatric
disorder according to the MINI and the prevalence might not exactly
match to the number of comorbidities as reported for our patient
group. Potential ADHD symptoms as well as sporadic depressive symp-
toms in the control group at the time of the sleep assessmentsmay have
inﬂuenced our reported group effects.
In conclusion, SWA topography seems to be a reliable mapping tool
that mirrors and/or precedes disturbed processes of cortical brain plas-
ticity and the perceptual disconnection from the environment during
sleep seems particularly relevant for research in children with mental
diseases. Our ﬁnding of increased frontal SWA in adolescents with
MDD may represent a promising biomarker tracing cortical regions of
extensive reorganization.Acknowledgements
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